Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M4,979Revenue (TTM) $M1,632Net Margin (%)24.2Altman Z-Score6.6
Enterprise Value $M4,113EPS (TTM) $8.6Operating Margin %46.9Piotroski F-Score5
P/E(ttm)13.3Beneish M-Score-3.2Pre-tax Margin (%)44.0Higher ROA y-yN
Price/Book2.810-y EBITDA Growth Rate %--Quick Ratio1.7Cash flow > EarningsY
Price/Sales3.25-y EBITDA Growth Rate %33.5Current Ratio1.9Lower Leverage y-yY
Price/Free Cash Flow8.3y-y EBITDA Growth Rate %-48.6ROA % (ttm)16.4Higher Current Ratio y-yN
Dividend Yield %--PEG0.4ROE % (ttm)21.1Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M43.4ROIC % (ttm)39.6Gross Margin Increase y-yN

Gurus Latest Trades with UTHR

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

UTHR is held by these investors:



UTHR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ROTHBLATT MARTINE AChairman & CEO 2017-09-21Sell1,274$116.07-1.27view
ROTHBLATT MARTINE AChairman & CEO 2017-09-14Sell1,258$122.08-6.13view
CAUSEY CHRISTOPHERDirector 2017-09-07Sell580$134.48-14.78view
ROTHBLATT MARTINE AChairman & CEO 2017-09-07Sell1,232$133.32-14.04view
ROTHBLATT MARTINE AChairman & CEO 2017-08-31Sell1,235$130.49-12.18view
ROTHBLATT MARTINE AChairman & CEO 2017-08-24Sell1,238$130.65-12.28view
ROTHBLATT MARTINE AChairman & CEO 2017-08-17Sell1,235$131.95-13.15view
ROTHBLATT MARTINE AChairman & CEO 2017-08-10Sell2,176$127.11-9.84view
ROTHBLATT MARTINE AChairman & CEO 2017-08-03Sell1,248$126.41-9.34view
ROTHBLATT MARTINE AChairman & CEO 2017-07-27Sell1,247$126.4-9.34view

Quarterly/Annual Reports about UTHR:

News about UTHR:

Articles On GuruFocus.com
Martine Rothblatt is Featured in Forbes Magazine's Special Centennial Issue as one of The World's 10 Sep 19 2017 
United Therapeutics Announces FREEDOM-EV Study Of Orenitram® To Continue As Planned Following Inter Sep 07 2017 
Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform Aug 21 2017 
United Therapeutics Corporation To Present At 2017 Wedbush PacGrow Healthcare Conference Aug 09 2017 
Lifshitz & Miller LLP Announces Investigation of EZCORP, Inc., Flowserve Corporation, Halliburton Co Aug 02 2017 
Harwood Feffer LLP Announces Investigation of United Therapeutics Corporation Jul 28 2017 
UNITED THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Ex Jul 27 2017 
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of United Therapeutics Jul 27 2017 
United Therapeutics Corporation to Report Second Quarter 2017 Financial Results Before The Market Op Jul 21 2017 
United Therapeutics Exhibits Some Value Jul 20 2017 

More From Other Websites
Is United Therapeutics a Great Stock for Value Investors? Sep 21 2017
Martine Rothblatt is Featured in Forbes Magazine's Special Centennial Issue as one of The World's... Sep 19 2017
See what the IHS Markit Score report has to say about United Therapeutics Corp. Sep 18 2017
United Therapeutics Corp. breached its 50 day moving average in a Bearish Manner : UTHR-US :... Sep 11 2017
Here's Why United Therapeutics Sank as Much as 10.8% Today Sep 08 2017
United Therapeutics Announces FREEDOM-EV Study Of Orenitram® To Continue As Planned Following... Sep 07 2017
United Therapeutics Corp. breached its 50 day moving average in a Bullish Manner : UTHR-US :... Sep 01 2017
How United Therapeutics’ Adcirca and Tyvaso Are Positioned in 3Q17 Sep 01 2017
Ligand Pharmaceuticals Focuses on Increasing Returns for Shareholders Sep 01 2017
How United Therapeutics’ Remodulin and Tyvaso Are Performing Aug 31 2017
Technology Platforms and Research Programs Drive LGND’s Partnerships Aug 31 2017
How Did United Therapeutics’ Orenitram and Unituxin Perform in 2Q17? Aug 31 2017
What Analysts Recommend for United Therapeutics in August 2017 Aug 30 2017
United Therapeutics Corp. – Value Analysis (NASDAQ:UTHR) : August 29, 2017 Aug 28 2017
Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform Aug 21 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}